PHF6通过调控NF-κB信号通路维持急性髓系白血病
该研究利用体内外模型发现,植物同源结构域指基因6(PHF6)在髓系白血病中发挥促癌作用,PHF6缺失可延缓RUNX1-ETO9a和MLL-AF9诱导的小鼠AML进展,其机制涉及破坏PHF6-p50复合物、抑制p50核转位及BCL2表达,NF-κB抑制剂可增加PHF6过表达细胞的凋亡并减少增殖。
要点
- PHF6缺失可延缓RUNX1-ETO9a和MLL-AF9诱导的小鼠AML进展。
- PHF6通过破坏PHF6-p50复合物、抑制p50核转位上调BCL2。
- NF-κB抑制剂BAY11-7082增加PHF6过表达髓系白血病细胞凋亡并减少增殖。
核心结论
- 与PHF6在T-ALL中作为抑癌基因的报道相反,本研究发现PHF6在髓系白血病中也发挥促癌作用,并可能成为治疗髓系白血病患者的治疗靶点。
研究设计与样本
- 研究采用体内和体外模型。
主要发现
- Phf6缺陷可延缓RUNX1-ETO9a和MLL-AF9诱导的小鼠AML进展。
- PHF6耗竭通过破坏PHF6-p50复合物并部分抑制p50核转位来抑制NF-κB信号通路,从而抑制BCL2表达。
- 用NF-κB抑制剂BAY11-7082处理PHF6过表达的髓系白血病细胞,可显著增加其凋亡并减少其增殖。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) is a major hematopoietic malignancy characterized by the accumulation of immature and abnormally differentiated myeloid cells in bone marrow. Here with in vivo and in vitro models, we demonstrate that the Plant homeodomain finger gene 6 (PHF6) plays an important role in apoptosis and proliferation in myeloid leukemia. Phf6 deficiency could delay the progression of RUNX1-ETO9a and MLL-AF9-induced AML in mice. PHF6 depletion inhibited the NF-κB signaling pathways by disrupting the PHF6-p50 complex and partially inhibiting the nuclear translocation of p50 to suppress the expression of BCL2. Treating PHF6 over-expressed myeloid leukemia cells with NF-κB inhibitor (BAY11-7082) significantly increased their apoptosis and decreased their proliferation. Taken together, in contrast to PHF6 as a tumor suppressor in T-ALL as reported, we found that PHF6 also plays a pro-oncogenic role in myeloid leukemia, and thus potentially to be a therapeutic target for treating myeloid leukemia patients.
引用
- Hou S, Wang X, Guo T, et al. PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway. Leukemia. 2023. PMID: 37393343. doi:10.1038/s41375-023-01953-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。